Antibiotic faces uncertain future.
Pearson
Helen
H
D000218:Adamantane; D062365:Aminobenzoates; D000617:Aminoglycosides / Q000145:classification* / Q000494:pharmacology*; D000813:Anilides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000145:classification* / Q000191:economics / Q000494:pharmacology*; D001419:Bacteria / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology*; D002473:Cell Wall / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical / Q000191:economics / Q000379:methods; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D005227:Fatty Acids / Q000096:biosynthesis / Q000378:metabolism; D006801:Humans; D051379:Mice
D062365:Aminobenzoates; D000617:Aminoglycosides; D000813:Anilides; D000900:Anti-Bacterial Agents; D005227:Fatty Acids; D000218:Adamantane; C510909:platensimycin